- Abstract:
-
Background
Aminosalicylates are the most frequently prescribed drugs for patients with Crohn’s disease (CD), yet evidence to support their efficacy as induction or maintenance therapy is controversial.
Aims
To quantify aminosalicylate use in CD clinical trials, identify factors associated with use, and estimate direct annual treatment costs of therapy.
Methods
MEDLINE, Embase, and CENTRAL were searched to April 2017 for placebo-controlled trials in...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted Manuscript
- Files:
-
-
(pdf, 783.0KB)
-
- Publisher copy:
- 10.1111/apt.14821
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
- Publisher:
- Wiley Publisher's website
- Journal:
- Alimentary Pharmacology & Therapeutics Journal website
- Volume:
- 48
- Issue:
- 2
- Pages:
- 114-126
- Publication date:
- 2018-05-30
- Acceptance date:
- 2018-05-02
- DOI:
- EISSN:
-
1365-2036
- ISSN:
-
0269-2813
- Pubs id:
-
pubs:854304
- URN:
-
uri:854e71cc-5c35-444d-a242-9713136c5481
- UUID:
-
uuid:854e71cc-5c35-444d-a242-9713136c5481
- Local pid:
- pubs:854304
- Copyright holder:
- Wiley
- Copyright date:
- 2018
- Notes:
- © 2018 John Wiley & Sons Ltd. This is the accepted manuscript version of the article. The final version is available online from Wiley Library at: 10.1111/apt.14821
Journal article
Systematic review and meta-analysis: Prevalence, risk factors, and costs of aminosalicylate use in Crohn’s disease
Actions
Access Document
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Canadian Association of Gastroenterology
More from this funder
Canadian Institutes of Health Research
More from this funder
American College of Gastroenterology
More from this funder
Crohn’s and Colitis Foundation
More from this funder
Bibliographic Details
Item Description
Terms of use
If you are the owner of this record, you can report an update to it here: Report update to this record